Cargando…
Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy
Immunotherapy is a promising modality of treatment for cancer. Immunotherapy is comprised of systemic and local treatments that induce an immune response, allowing the body to fight back against cancer. Systemic treatments such as cancer vaccines harness antigen presenting cells (APCs) to activate T...
Autores principales: | Yu, Albert, Dai, Xiaoyong, Wang, Zixian, Chen, Huaqing, Guo, Bing, Huang, Laiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869707/ https://www.ncbi.nlm.nih.gov/pubmed/35200369 http://dx.doi.org/10.3390/bios12020109 |
Ejemplares similares
-
Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
por: Yu, Albert, et al.
Publicado: (2022) -
Mesoporous silica/organosilica nanoparticles for cancer immunotherapy
por: Theivendran, Shevanuja, et al.
Publicado: (2023) -
Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy
por: Escriche‐Navarro, Blanca, et al.
Publicado: (2022) -
Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
por: Xie, Xiaowei, et al.
Publicado: (2023) -
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
por: Narayan, Reema, et al.
Publicado: (2018)